Trade Elekta B - EKTAb CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
| Spread | 0.45 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.02194% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | -0.000282% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | SEK | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | Sweden | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Elekta AB (publ) ESG Risk Ratings
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
| Prev. Close* | 75.75 |
| Open* | 76.8 |
| 1-Year Change* | -8.3% |
| Day's Range* | 76.15 - 76.8 |
| 52 wk Range | 69.10-90.42 |
| Average Volume (10 days) | 862.15K |
| Average Volume (3 months) | 23.79M |
| Market Cap | 28.74B |
| P/E Ratio | 22.21 |
| Shares Outstanding | 382.08M |
| Revenue | 18.02B |
| EPS | 3.51 |
| Dividend (Yield %) | 3.0785 |
| Beta | 0.95 |
| Next Earnings Date | Feb 22, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 22, 2024 | 75.75 | 1.00 | 1.34% | 74.75 | 77.50 | 73.95 |
| Apr 19, 2024 | 74.25 | 0.20 | 0.27% | 74.05 | 74.65 | 73.50 |
| Apr 18, 2024 | 74.75 | -0.75 | -0.99% | 75.50 | 75.90 | 74.30 |
| Apr 17, 2024 | 75.45 | -0.60 | -0.79% | 76.05 | 76.95 | 74.85 |
| Apr 16, 2024 | 76.75 | -0.10 | -0.13% | 76.85 | 77.60 | 76.35 |
| Apr 15, 2024 | 77.60 | 0.95 | 1.24% | 76.65 | 78.35 | 76.65 |
| Apr 12, 2024 | 76.55 | -2.15 | -2.73% | 78.70 | 79.15 | 76.50 |
| Apr 11, 2024 | 78.40 | 0.80 | 1.03% | 77.60 | 79.75 | 75.90 |
| Apr 10, 2024 | 80.25 | -0.15 | -0.19% | 80.40 | 82.40 | 80.10 |
| Apr 9, 2024 | 80.70 | -1.50 | -1.82% | 82.20 | 83.50 | 80.55 |
| Apr 8, 2024 | 83.00 | 1.60 | 1.97% | 81.40 | 83.05 | 81.15 |
| Apr 5, 2024 | 81.85 | -0.05 | -0.06% | 81.90 | 83.05 | 81.40 |
| Apr 4, 2024 | 83.80 | 0.30 | 0.36% | 83.50 | 84.35 | 82.85 |
| Apr 3, 2024 | 83.40 | 1.65 | 2.02% | 81.75 | 83.55 | 80.90 |
| Apr 2, 2024 | 82.40 | 2.00 | 2.49% | 80.40 | 82.65 | 80.30 |
| Mar 28, 2024 | 80.65 | 0.00 | 0.00% | 80.65 | 81.40 | 79.95 |
| Mar 27, 2024 | 80.50 | 0.90 | 1.13% | 79.60 | 81.00 | 79.60 |
| Mar 26, 2024 | 80.35 | 0.05 | 0.06% | 80.30 | 80.45 | 78.35 |
| Mar 25, 2024 | 80.40 | 1.15 | 1.45% | 79.25 | 80.60 | 78.95 |
| Mar 22, 2024 | 79.90 | 1.40 | 1.78% | 78.50 | 81.15 | 78.50 |
Elekta B Events
| Time (UTC) | Country | Event |
|---|---|---|
| Saturday, May 4, 2024 | ||
| Time (UTC) 10:59 | Country SE
| Event Elekta AB (publ) ESTRO Investor Meeting Elekta AB (publ) ESTRO Investor MeetingForecast -Previous - |
| Wednesday, June 5, 2024 | ||
| Time (UTC) 05:30 | Country SE
| Event Q4 2024 Elekta AB (publ) Earnings Release Q4 2024 Elekta AB (publ) Earnings ReleaseForecast -Previous - |
| Thursday, September 5, 2024 | ||
| Time (UTC) 05:00 | Country SE
| Event Q1 2025 Elekta AB (publ) Earnings Release Q1 2025 Elekta AB (publ) Earnings ReleaseForecast -Previous - |
| Time (UTC) 10:59 | Country SE
| Event Elekta AB (publ) Annual Shareholders Meeting Elekta AB (publ) Annual Shareholders MeetingForecast -Previous - |
- Annual
- Quarterly
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Total revenue | 16869 | 14548 | 13763 | 14601 | 13555 |
| Revenue | 16869 | 14548 | 13763 | 14601 | 13555 |
| Cost of Revenue, Total | 10449 | 9111 | 8153 | 8464 | 7875 |
| Gross Profit | 6420 | 5437 | 5610 | 6137 | 5680 |
| Total Operating Expense | 15438 | 12905 | 11857 | 12944 | 11859 |
| Selling/General/Admin. Expenses, Total | 2381 | 2122 | 1842 | 2133 | 2138 |
| Research & Development | 374 | 840 | 765 | 871 | 892 |
| Depreciation / Amortization | 1423 | 938 | 1108 | 1190 | 897 |
| Interest Expense (Income) - Net Operating | 434 | -155 | -97 | 298 | 80 |
| Unusual Expense (Income) | 312 | -70 | |||
| Other Operating Expenses, Total | 65 | 49 | 86 | -12 | 47 |
| Operating Income | 1431 | 1643 | 1906 | 1657 | 1696 |
| Interest Income (Expense), Net Non-Operating | -150 | -88 | -215 | -151 | -86 |
| Other, Net | -83 | -54 | -61 | -52 | -30 |
| Net Income Before Taxes | 1198 | 1501 | 1630 | 1454 | 1580 |
| Net Income After Taxes | 944 | 1156 | 1253 | 1084 | 1198 |
| Minority Interest | -1 | -3 | 1 | 0 | 0 |
| Net Income Before Extra. Items | 943 | 1153 | 1254 | 1084 | 1198 |
| Net Income | 943 | 1153 | 1254 | 1084 | 1198 |
| Income Available to Common Excl. Extra. Items | 943 | 1154 | 1254 | 1084 | 1198 |
| Income Available to Common Incl. Extra. Items | 943 | 1154 | 1254 | 1084 | 1198 |
| Diluted Net Income | 943 | 1154 | 1254 | 1084 | 1198 |
| Diluted Weighted Average Shares | 382.367 | 382.083 | 382.083 | 382.062 | 382.027 |
| Diluted EPS Excluding Extraordinary Items | 2.46622 | 3.02029 | 3.28201 | 2.83724 | 3.1359 |
| Dividends per Share - Common Stock Primary Issue | 2.4 | 2.4 | 2.2 | 1.8 | 1.8 |
| Diluted Normalized EPS | 3.10919 | 3.02029 | 3.28201 | 2.83724 | 2.99697 |
| Total Adjustments to Net Income | 1 |
| Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | |
|---|---|---|---|---|---|
| Total revenue | 3828 | 5124 | 4337 | 4081 | 3327 |
| Revenue | 3828 | 5124 | 4337 | 4081 | 3327 |
| Cost of Revenue, Total | 2237 | 3187 | 2674 | 2557 | 2032 |
| Gross Profit | 1591 | 1937 | 1663 | 1524 | 1295 |
| Total Operating Expense | 3416 | 4340 | 4006 | 3882 | 3210 |
| Selling/General/Admin. Expenses, Total | 734 | 696 | 703 | 723 | 701 |
| Research & Development | 253 | 167 | 225 | 217 | 278 |
| Depreciation / Amortization | 133 | 124 | 126 | 113 | 112 |
| Interest Expense (Income) - Net Operating | 31 | 98 | 126 | 142 | 68 |
| Other Operating Expenses, Total | 13 | 19 | 19 | 13 | 5 |
| Operating Income | 412 | 784 | 331 | 199 | 117 |
| Interest Income (Expense), Net Non-Operating | -107 | -96 | -58 | -40 | -39 |
| Net Income Before Taxes | 305 | 688 | 273 | 160 | 78 |
| Net Income After Taxes | 238 | 546 | 216 | 122 | 60 |
| Minority Interest | 0 | -1 | 0 | 0 | 0 |
| Net Income Before Extra. Items | 238 | 545 | 216 | 122 | 60 |
| Net Income | 238 | 545 | 216 | 122 | 60 |
| Income Available to Common Excl. Extra. Items | 238 | 546 | 216 | 121 | 60 |
| Income Available to Common Incl. Extra. Items | 238 | 546 | 216 | 121 | 60 |
| Diluted Net Income | 238 | 546 | 216 | 121 | 60 |
| Diluted Weighted Average Shares | 382.596 | 383.468 | 382 | 382.083 | 382.083 |
| Diluted EPS Excluding Extraordinary Items | 0.62207 | 1.42385 | 0.56545 | 0.31669 | 0.15703 |
| Dividends per Share - Common Stock Primary Issue | 0 | 1.2 | 0 | 1.2 | 0 |
| Diluted Normalized EPS | 0.65266 | 1.52526 | 0.84092 | 0.55017 | 0.18522 |
| Total Adjustments to Net Income | 1 | -1 | |||
| Other, Net | 1 | ||||
| Unusual Expense (Income) | 15 | 49 | 133 | 117 | 14 |
- Annual
- Quarterly
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Total Current Assets | 14375 | 12880 | 13247 | 15566 | 12897 |
| Cash and Short Term Investments | 3278 | 3077 | 4411 | 6469 | 4118 |
| Cash & Equivalents | 2364 | 3074 | 3619 | 5166 | 2357 |
| Short Term Investments | 914 | 3 | 792 | 1303 | 1761 |
| Total Receivables, Net | 7035 | 6350 | 5800 | 5597 | 5488 |
| Accounts Receivable - Trade, Net | 6109 | 5443 | 5053 | 4905 | 4856 |
| Total Inventory | 3070 | 2533 | 2283 | 2748 | 2634 |
| Prepaid Expenses | 879 | 793 | 534 | 654 | 585 |
| Other Current Assets, Total | 113 | 127 | 219 | 98 | 72 |
| Total Assets | 29608 | 26303 | 24844 | 28411 | 24064 |
| Property/Plant/Equipment, Total - Net | 1753 | 1929 | 1850 | 2124 | 957 |
| Property/Plant/Equipment, Total - Gross | 3638 | 3635 | 3329 | 3579 | 2254 |
| Accumulated Depreciation, Total | -1885 | -1705 | -1479 | -1455 | -1298 |
| Goodwill, Net | 6937 | 6499 | 5973 | 6302 | 5914 |
| Intangibles, Net | 4785 | 3763 | 2806 | 3167 | 3387 |
| Long Term Investments | 1056 | 615 | 533 | 748 | 508 |
| Note Receivable - Long Term | |||||
| Other Long Term Assets, Total | 702 | 617 | 435 | 504 | 401 |
| Total Current Liabilities | 12706 | 11564 | 11941 | 11300 | 11897 |
| Accounts Payable | 1809 | 1352 | 1016 | 1025 | 1427 |
| Accrued Expenses | 1994 | 1901 | 1837 | 1703 | 1661 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 250 | 755 | 2341 | 1214 | 1000 |
| Other Current Liabilities, Total | 8653 | 7556 | 6747 | 7358 | 7809 |
| Total Liabilities | 19879 | 17390 | 16647 | 20299 | 16286 |
| Total Long Term Debt | 6418 | 4940 | 3897 | 8144 | 3558 |
| Long Term Debt | 5706 | 4099 | 3043 | 7101 | 3558 |
| Deferred Income Tax | 473 | 549 | 515 | 545 | 587 |
| Minority Interest | 4 | 3 | 0 | 1 | 1 |
| Other Liabilities, Total | 278 | 334 | 294 | 309 | 243 |
| Total Equity | 9729 | 8913 | 8197 | 8112 | 7778 |
| Common Stock | 192 | 192 | 192 | 192 | 192 |
| Retained Earnings (Accumulated Deficit) | 6912 | 6882 | 6568 | 5830 | 5555 |
| Other Equity, Total | 2625 | 1839 | 1437 | 2090 | 2031 |
| Total Liabilities & Shareholders’ Equity | 29608 | 26303 | 24844 | 28411 | 24064 |
| Total Common Shares Outstanding | 382.083 | 382.083 | 382.083 | 383.568 | 382.027 |
| Capital Lease Obligations | 712 | 841 | 854 | 1043 |
| Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | |
|---|---|---|---|---|---|
| Total Current Assets | 14826 | 14375 | 13246 | 12526 | 12394 |
| Cash and Short Term Investments | 2367 | 3278 | 1218 | 1535 | 2423 |
| Cash & Equivalents | 2367 | 3278 | 1218 | 1535 | 2423 |
| Short Term Investments | |||||
| Total Receivables, Net | 8728 | 7914 | 8691 | 7775 | 6982 |
| Accounts Receivable - Trade, Net | 6531 | 6109 | 6526 | 5713 | 5125 |
| Total Inventory | 3732 | 3070 | 3337 | 3216 | 2990 |
| Other Current Assets, Total | -1 | 113 | -1 | ||
| Total Assets | 30822 | 29608 | 27971 | 27225 | 26322 |
| Property/Plant/Equipment, Total - Net | 1773 | 1753 | 1794 | 1892 | 1907 |
| Intangibles, Net | 12450 | 11722 | 11492 | 11390 | 10666 |
| Long Term Investments | 1041 | 1056 | 726 | 720 | 719 |
| Other Long Term Assets, Total | 732 | 702 | 713 | 697 | 636 |
| Total Current Liabilities | 13287 | 12706 | 12679 | 12318 | 11499 |
| Accounts Payable | 1690 | 1809 | 1390 | 1464 | 1280 |
| Accrued Expenses | 1909 | 1994 | 1937 | 1835 | 1606 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 232 | 250 | 758 | 787 | 780 |
| Other Current Liabilities, Total | 9456 | 8653 | 8594 | 8232 | 7833 |
| Total Liabilities | 20609 | 19879 | 18347 | 18098 | 17243 |
| Total Long Term Debt | 6514 | 6418 | 4881 | 4922 | 4919 |
| Long Term Debt | 5783 | 5706 | 4152 | 4138 | 4112 |
| Capital Lease Obligations | 731 | 712 | 729 | 784 | 807 |
| Deferred Income Tax | 456 | 473 | 487 | 503 | 483 |
| Minority Interest | 5 | 4 | 4 | 4 | 3 |
| Other Liabilities, Total | 347 | 278 | 296 | 351 | 339 |
| Total Equity | 10213 | 9729 | 9624 | 9127 | 9079 |
| Other Equity, Total | 10213 | 9729 | 9624 | 9127 | 9079 |
| Total Liabilities & Shareholders’ Equity | 30822 | 29608 | 27971 | 27225 | 26322 |
| Total Common Shares Outstanding | 382.083 | 382.083 | 382.083 | 382.083 | 382.083 |
- Annual
- Quarterly
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 1198 | 1501 | 1630 | 1454 | 1580 |
| Cash From Operating Activities | 1964 | 1858 | 2551 | 1014 | 1621 |
| Cash From Operating Activities | 1062 | 1039 | 1204 | 1275 | 943 |
| Non-Cash Items | 299 | -105 | 511 | 204 | 112 |
| Cash Taxes Paid | 290 | 452 | 465 | 261 | 269 |
| Cash Interest Paid | 156 | 249 | 208 | 175 | |
| Changes in Working Capital | -595 | -577 | -794 | -1919 | -1014 |
| Cash From Investing Activities | -1615 | -1649 | -613 | -1298 | -674 |
| Capital Expenditures | -1564 | -1408 | -845 | -762 | -659 |
| Other Investing Cash Flow Items, Total | -51 | -241 | 232 | -536 | -15 |
| Cash From Financing Activities | -129 | -1726 | -3605 | 2624 | -1473 |
| Financing Cash Flow Items | 788 | 1 | 1 | 1 | 0 |
| Total Cash Dividends Paid | -917 | -841 | -688 | -688 | -535 |
| Issuance (Retirement) of Debt, Net | -886 | -2918 | 3311 | -938 | |
| Foreign Exchange Effects | -18 | 183 | -329 | -5 | 142 |
| Net Change in Cash | 202 | -1334 | -1996 | 2335 | -384 |
| Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 1198 | 510 | 237 | 78 | 1501 |
| Cash From Operating Activities | 1964 | -27 | -253 | -198 | 1858 |
| Cash From Operating Activities | 1062 | 803 | 528 | 262 | 1039 |
| Non-Cash Items | 299 | 187 | -45 | 61 | -105 |
| Cash Taxes Paid | 290 | 251 | 178 | 33 | 452 |
| Cash Interest Paid | 156 | ||||
| Changes in Working Capital | -595 | -1527 | -973 | -599 | -577 |
| Cash From Investing Activities | -1615 | -1184 | -760 | -394 | -1649 |
| Capital Expenditures | -1564 | -1146 | -758 | -395 | -1408 |
| Other Investing Cash Flow Items, Total | -51 | -38 | -2 | 1 | -241 |
| Cash From Financing Activities | -129 | -661 | -564 | -45 | -1726 |
| Financing Cash Flow Items | 788 | -202 | -105 | -45 | 1 |
| Total Cash Dividends Paid | -917 | -459 | -459 | -841 | |
| Issuance (Retirement) of Debt, Net | -886 | ||||
| Foreign Exchange Effects | -18 | 14 | 34 | -16 | 183 |
| Net Change in Cash | 202 | -1858 | -1543 | -653 | -1334 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Elekta Company profile
About Elekta AB (publ)
Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).
Financial summary
BRIEF: For the nine months ended 31 January 2022, Elekta AB (publ) revenues increased 2% to SEK10.31B. Net income decreased 19% to SEK738M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Europe, Middle East and Africa segment income decrease of 63% to SEK481M, Asia Pacific segment income decrease of 66% to SEK402M.
Equity composition
10/2005, 3-for-1 stock split. 9/2012, 4-for-1 stock split (Factor: 4).
| Industry: | Advanced Medical Equipment & Technology (NEC) |
Kungstensgatan 18
STOCKHOLM
STOCKHOLM 113 57
SE
Income Statement
- Annual
- Quarterly
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com